Journey Medical Corporation
DERM
Rank in Stocks
#18612
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale,... Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
Share Price
$4.52
Last synced: 2026-11-09
Market Cap
$127.57M
Change (1 day)
1.12%
Change (1 year)
-50.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Journey Medical Corporation (DERM)
Category
Healthcare
EPS for Journey Medical Corporation (DERM)
EPS as of June 2026 TTM: $-0.23
According to Journey Medical Corporation's latest financial reports, its current EPS (TTM) is $-0.23. At the end of 2025 the company had an EPS of $-0.47, an increase over its 2024 EPS of $-0.72.
EPS history for Journey Medical Corporation from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.23 | -51.06% |
| 2025 | $-0.47 | -34.72% |
| 2024 | $-0.72 | 242.86% |
| 2023 | $-0.21 | -87.57% |
| 2022 | $-1.69 | -33.46% |
| 2021 | $-2.54 | -893.75% |
| 2020 | $0.32 | 45.45% |
| 2019 | $0.22 | -104.17% |
| 2018 | $-5.27 | -29.55% |
| 2017 | $-7.48 | 177.04% |
| 2016 | $-2.70 | -7.85% |
| 2015 | $-2.93 | 127.13% |
| 2014 | $-1.29 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -2,926.70% |
DE
|
|
| $6.08 | -2,742.43% |
DE
|
|
| $1.55 | -774.17% |
JP
|
|
| $3.66 | -1,691.30% |
CH
|
|
| $0.45 | -295.65% |
IL
|
Questions about Journey Medical Corporation's earnings per share (EPS)
What is Journey Medical Corporation's earnings per share (EPS)?
Journey Medical Corporation's earnings per share (EPS) over the last twelve months is $-0.23, as of Jun 2026.
What was Journey Medical Corporation's earnings per share (EPS) in 2025?
In 2025, Journey Medical Corporation's earnings per share (EPS) was $-0.47, compared with $-0.72 in 2024.
How has Journey Medical Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Journey Medical Corporation's earnings per share (EPS) was highest in 2020 ($0.32) and lowest in 2021 ($-2.54).
How does Journey Medical Corporation's earnings per share (EPS) compare with similar companies?
Journey Medical Corporation's earnings per share (EPS) ($-0.23) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.